← back to search

Wouter Froyman

KU Leuven · BE
Area of research
Reproductive Medicine · Obstetrics and Gynecology
Research interest
Research focused on Risk stratification and Malignancy, with related work in Lexicon, Statement (logic), Ovarian cancer. Notable publications include 'O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee', 'Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group', and 'Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study'.
h-index
citations
2,276
works
25
NIH funding
primary concept
email

Recent publications

Circulating tumor DNA in the diagnosis of ovarian cancer: a systematic review
International Journal of Gynecological Cancer 2025cited by 4position: middledoi
Accessory cavitated uterine malformation (<scp>ACUM</scp>): A scoping review
Acta Obstetricia Et Gynecologica Scandinavica 2024cited by 34position: lastdoi
Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis
International Journal of Gynecological Cancer 2024cited by 19position: middledoi
O-RADS US v2022: An Update from the American College of Radiology’s Ovarian-Adnexal Reporting and Data System US Committee
Radiology 2023cited by 89position: middledoi
Elastography in ultrasound assessment of the uterus
Journal of Endometriosis and Uterine Disorders 2023cited by 10position: middledoi
Benign descriptors and <scp>ADNEX</scp> in two‐step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in <scp>IOTA5</scp> multicenter cohort
Ultrasound in Obstetrics and Gynecology 2022cited by 56position: middledoi
External Validation of the Ovarian-Adnexal Reporting and Data System (<scp>O-RADS)</scp> Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into <scp>O-RADS</scp> Risk Groups
JAMA Oncology 2022cited by 47position: lastdoi
Imaging in gynecological disease (24): clinical and ultrasound characteristics of ovarian mature cystic teratomas
Ultrasound in Obstetrics and Gynecology 2022cited by 30position: lastdoi
Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer
npj Genomic Medicine 2022cited by 25position: middledoi
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors
International Journal of Gynecological Cancer 2021cited by 138position: middledoi
<scp>ESGO</scp>/<scp>ISUOG</scp>/<scp>IOTA</scp>/<scp>ESGE</scp> Consensus Statement on preoperative diagnosis of ovarian tumors
Ultrasound in Obstetrics and Gynecology 2021cited by 103position: middledoi
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer
Journal for ImmunoTherapy of Cancer 2021cited by 41position: middledoi
Safety and efficiency of performing transvaginal ultrasound-guided tru-cut biopsy for pelvic masses
Gynecologic Oncology 2021cited by 21position: middledoi
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study
BMJ 2020cited by 124position: middledoi
Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors)
Ultrasound in Obstetrics and Gynecology 2020cited by 32position: middledoi
O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee
Radiology 2019cited by 471position: middledoi
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study
The Lancet Oncology 2019cited by 188position: firstdoi
Methods of Assessing Ovarian Masses
Obstetrics and Gynecology Clinics of North America 2019cited by 43position: firstdoi
Ovarian-Adnexal Reporting Lexicon for Ultrasound: A White Paper of the ACR Ovarian-Adnexal Reporting and Data System Committee
Journal of the American College of Radiology 2018cited by 170position: middledoi
Imaging in gynecological disease (13): clinical and ultrasound characteristics of endometrioid ovarian cancer
Ultrasound in Obstetrics and Gynecology 2018cited by 42position: middledoi
Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve Analysis
Clinical Cancer Research 2017cited by 49position: middledoi
Validation of the Performance of International Ovarian Tumor Analysis (IOTA) Methods in the Diagnosis of Early Stage Ovarian Cancer in a Non-Screening Population
Diagnostics 2017cited by 44position: firstdoi
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
American Journal of Obstetrics and Gynecology 2016cited by 327position: middledoi
Age-related differences in the sonographic characteristics of endometriomas
Human Reproduction 2016cited by 65position: middledoi
Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors.
PubMed 2015cited by 104position: middle

Grants

No grants ingested yet.

Frequent collaborators

D. Timmerman · Zero to Three19 papers (2015–2025)T. Bourne · Luigi Sacco Hospital11 papers (2015–2022)A. C. Testa · Università Cattolica del Sacro Cuore10 papers (2016–2022)D. Fischerová · Charles University8 papers (2016–2021)Ignace Vergote · KU Leuven7 papers (2015–2022)C. Landolfo · Imperial College Healthcare NHS Trust7 papers (2015–2022)Ben Van Calster · University Medical Center Utrecht6 papers (2015–2022)L. Valentin · Lund University6 papers (2016–2022) · 5 papers (2016–2020)E. Epstein · Karolinska Institutet5 papers (2016–2022) · 5 papers (2016–2020)Caroline Van Holsbeke · KU Leuven4 papers (2016–2021)An Coosemans · KU Leuven4 papers (2016–2025)Laure Wynants · KU Leuven4 papers (2015–2017) · 4 papers (2016–2018)Dominique Van Schoubroeck · KU Leuven3 papers (2021–2024)Nicole Concin · Texas Oncology3 papers (2021–2022)Giovanni Scambia · PromoFirenze3 papers (2018–2021)Lori M. Strachowski · University of California, San Francisco3 papers (2018–2023)Caroline Reinhold · McGill University Health Centre3 papers (2018–2023)